Skip to content

Compounds

KLOW

On NovaEvumFull protocol

1–2.5 mg GHK-Cu daily (blend)

Reconstitution

Concentration by vial size and water volume
Vial3 mL water4 mL water5 mL water
80 mg26.67 mg/mL20 mg/mL16 mg/mL

KLOW is a blend (GHK-Cu, BPC-157, TB-500, KPV in a 5:1:1:1 ratio), so 80 mg is the combined weight. The NovaEvum worksheet uses 4 mL (20 mg/mL total). More water dilutes the GHK-Cu sting. The calculator works in total blend mg: since GHK-Cu is 5 of every 8 parts, 1.25 mg of GHK-Cu is 2 mg of total blend.

  1. Use bacteriostatic water as the diluent.
  2. Add the water slowly, letting it run down the inside wall of the vial rather than onto the powder.
  3. Swirl gently to mix, then leave it to dissolve. Do not shake.
  4. Give it a few minutes. The finished solution should be clear and colourless.
  5. A faint blue tint from the copper is normal.
  6. The solution should otherwise be clear once mixed.

Full mixing method

Protocol

Route: Subcutaneous

How a blend is dosed

  • Like GLOW, dose KLOW by the GHK-Cu amount; the BPC-157, TB-500 and KPV follow in the 5:1:1:1 ratio
  • The common range is 1 mg to 2.5 mg of GHK-Cu per day. Start around 1.25 mg and move toward 2.5 mg during loading if tolerated
  • At a 4 mL fill the GHK-Cu portion comes to 12.5 mg/mL, so 1.25 mg of GHK-Cu (2 mg of blend) is a 0.1 mL draw (10 units) and 2.5 mg is 0.2 mL (20 units)
  • These figures are for a 4 mL fill; with any other fill, recalculate the draws

Schedule

  • One subcutaneous injection daily, or 5 days on, 2 days off, rotating sites
  • Run an 8 to 12 week block, then 4 to 8 weeks off
  • Inject slowly to limit the GHK-Cu sting
  • KLOW adds KPV, so it leans more anti-inflammatory than GLOW

Dosing detail

  • Dose by GHK-Cu content, 1 mg to 2.5 mg daily, scaling the rest of the blend with it. Around 2.5 mg is common during loading.
  • Once daily, subcutaneous, sites rotated.
  • Inject slowly given the copper content.

Duration

  • Typically run 8 to 12 weeks, often 5 days on and 2 off (or daily loading then 3 times weekly), then 4 to 8 weeks off and reassess.

Notes

  • Adds KPV (an anti-inflammatory tripeptide) to the GLOW base of GHK-Cu, BPC-157 and TB-500.
  • Inject subcutaneously and rotate sites.
  • Inject slowly given the copper content.

Storage and handling

  • Keep the powdered (lyophilized) vial in a cool, dark place. Refrigerate it for longer-term storage before mixing.
  • Once reconstituted and refrigerated at 2–8 °C away from light, use the vial within 28 days.
  • Do not freeze a reconstituted vial, and keep it away from heat and sunlight.
  • If the solution turns cloudy, develops floating particles, or shows any other sign of degradation, stop using that vial.
  • A faint blue tint is normal because of the GHK-Cu in the blend, not a sign of degradation.

Storage rules and when to discard

NovaEvum vial

Worksheet

4 mL bacteriostatic water yields 20 mg/mL total. A 0.1 mL (10 unit) draw is 2 mg total peptide: 1.25 mg GHK-Cu and 0.25 mg of each of the other three.

Catalog fill
80 mg blend
Typical water
4 mL
Route
Subcutaneous
Cycle
8–12 weeks, then 4–8 weeks off.
StepAmountFrequencyNotes
Daily research draw2 mg totalOnce daily10 units from a 4 mL reconstitution
Smaller daily draw1 mg totalOnce daily5 units
  • The certificate of analysis is the record of the actual fill. This worksheet uses the labelled split.
  • Do not add extra BPC-157, TB-500, KPV, or GHK-Cu on top without subtracting what KLOW already contributes.
  • Bacteriostatic water: 20–25 °C. Do not refrigerate the diluent.
  • Amounts on this sheet are reconstitution math for the vial, not a recommendation.